MG UCB Shroff MG0007 2020 An Open-Label Extension Study to Evaluate Rozanolixizumab in Study Participants With Generalized Myasthenia Gravis

Project: Clinical Trial

Project Details

StatusActive
Effective start/end date11/30/21 → …